Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0

Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

August 6, 2021 0

Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

August 4, 2021 0

Novartis Partial Clinical Trial Hold for OAV-101 IT for SMA Lifted Novartis (NVS) announced that the …

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

August 3, 2021 0

Sanofi Will Acquire Translate Bio Sanofi (SNY) will acquire all the outstanding shares of Translate Bio (

AstraZeneca: Big Step Towards Improving the Lives of SLE Patients and More on Cassava Sciences

August 2, 2021 0

Cassava Sciences There is no doubt in our minds that Cassava Sciences’ (SAVA) product simufilam will …

Cassava Sciences Good News and an Unwarranted Sell-Off. A New Drug Approval for Bristol-Myers Squibb and ImmunoGen Quarterly Results

July 30, 2021 0

Cassava Sciences Inc Following Cassava Sciences Inc successful and promising presentations, all the titles of the …

Cassava Sciences Inc: Today’s Press Releases

July 29, 2021 0

Cassava Sciences Inc Press Release Related to Positive Biomarker Data Cassava Sciences Inc (SAVA) announced today, …

GlaxoSmithKline and Vir Biotechnology Announce Joint Procurement Agreement with the EC for COVID-19 Treatment

July 28, 2021 0

GlaxoSmithKline and Vir Biotechnology Signed a Joint Procurement Agreement with the EC GlaxoSmithKline (GSK) and Vir Biotechnology …

Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

July 26, 2021 0

Cassava Sciences: Positive Clinical Data with SavaDX Cassava Sciences (SAVA) today announced positive clinical data with SavaDx, …

bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

July 22, 2021 0

bluebird bio Receives EC Approval for bluebird bio (BLUE) announced that the European Commission (EC) has granted marketing authorization …

Cassava Sciences Stock Soared. See Also: The Resurrection of Sunesis Pharmaceuticals

July 21, 2021 0

Cassava Sciences Soared Cassava Sciences (SAVA) stock soared today. The firm announced that it will present two …

Immunome Inc Stock Rallied After Announcing it Neutralized the SARS-CoV-2 Delta Variant.

July 20, 2021 0

Immunome Inc: Neutralizing SARS-C0V-2 Delta Variant Immunome Inc (IMNM) is a small biotech firm whose stock …

Why Cytokinetics’ Stock Price Soared in a Bad Market Day

July 19, 2021 0

Cytokinetics Positive Topline Results of CK-274 Cytokinetics (CYTK) announced positive topline results of Phase 2 clinical …

Important Steps Forward Taken by Vir Biotechnology and Separately by Compugen

July 15, 2021 0

Vir Biotechnology Vir Biotechnology (VIR) announced the dosing of the first patient in the Phase 2 …

Encouraging News from Hoth Therapeutics and Kintor Pharmaceutical Ltd About Treating Acne and Alopecia

July 14, 2021 0

Hoth Therapeutics Hoth Therapeutics (HOTH) announced that its product, HT-003, has yielded positive results in an …

Halozyme Announced Janssen Received U.S. FDA Approval of DARZALEX FASPRO®. See Also: IVERIC bio News

July 13, 2021 0

Halozyme Therapeutics Announced US FDA Approval for Janssen Biotech's DARZALEX FASPRO® Halozyme Therapeutics (HALO) announced that …

Companies Behind the Biotechnology Revolution

July 12, 2021 0

Prohost Portfolio PLUS #7 Companies Behind The Biotechnology Revolution Without these firms, basic science discoveries in …

Why Celldex Therapeutics Stock is Soaring

July 11, 2021 0

Celldex Therapeutics is Soaring Celldex Therapeutics (CLDX) stock soared following the firm’s announcement of updated data …

Important News and Results from Two Companies in the Prohost Portfolio

July 9, 2021 0

Important News and Results from Akero Therapeutics Akero Therapeutics (AKRO) announced that full results of the …

IVERIC bio Receives FDA Agreement Under an SPA for GATHER2 Phase 3 Clinical Trial of Zimura®

July 6, 2021 0

IVERIC bio GATHER2 Trial of Zimura® for Geographic Atrophy IVERIC Bio (ISEE) announced that it received …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

A Reevaluation of Prohost Biotech’s Picked Firms

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

AstraZeneca: Big Step Towards Improving the Lives of SLE Patients and More on Cassava Sciences

Cassava Sciences Good News and an Unwarranted Sell-Off. A New Drug Approval for Bristol-Myers Squibb and ImmunoGen Quarterly Results

Cassava Sciences Inc: Today’s Press Releases

GlaxoSmithKline and Vir Biotechnology Announce Joint Procurement Agreement with the EC for COVID-19 Treatment

Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

Cassava Sciences Stock Soared. See Also: The Resurrection of Sunesis Pharmaceuticals

Immunome Inc Stock Rallied After Announcing it Neutralized the SARS-CoV-2 Delta Variant.

Why Cytokinetics’ Stock Price Soared in a Bad Market Day

Important Steps Forward Taken by Vir Biotechnology and Separately by Compugen

Encouraging News from Hoth Therapeutics and Kintor Pharmaceutical Ltd About Treating Acne and Alopecia

Halozyme Announced Janssen Received U.S. FDA Approval of DARZALEX FASPRO®. See Also: IVERIC bio News

Companies Behind the Biotechnology Revolution

Why Celldex Therapeutics Stock is Soaring

Important News and Results from Two Companies in the Prohost Portfolio

IVERIC bio Receives FDA Agreement Under an SPA for GATHER2 Phase 3 Clinical Trial of Zimura®